Development and Validation of a Risk Model for Predicting Adverse Drug Reactions in Older People during Hospital Stay: Brighton Adverse Drug Reactions Risk (BADRI) Model

Background Older patients are at an increased risk of developing adverse drug reactions (ADR). Of particular concern are the oldest old, which constitute an increasingly growing population. Having a validated clinical tool to identify those older patients at risk of developing an ADR during hospital stay would enable healthcare staff to put measures in place to reduce the risk of such an event developing. The current study aimed to (1) develop and (2) validate an ADR risk prediction model. Methods We used a combination of univariate analysis and multivariate binary logistic regression to identify clinical risk factors for developing an ADR in a population of older people from a UK teaching hospital. The final ADR risk model was then validated in a European population (European dataset). Results Six-hundred-ninety patients (median age 85 years) were enrolled in the development stage of the study. Ninety-five reports of ADR were confirmed by independent review in these patients. Five clinical variables were identified through multivariate analysis and included in our final model; each variable was attributed a score of 1. Internal validation produced an AUROC of 0.74, a sensitivity of 80%, and specificity of 55%. During the external validation stage the AUROC was 0.73, with sensitivity and specificity values of 84% and 43% respectively. Conclusions We have developed and successfully validated a simple model to use ADR risk score in a population of patients with a median age of 85, i.e. the oldest old. The model is based on 5 clinical variables (≥8 drugs, hyperlipidaemia, raised white cell count, use of anti-diabetic agents, length of stay ≥12 days), some of which have not been previously reported.

[1]  L. Becquemont,et al.  Identifying and preventing adverse drug events in elderly hospitalised patients: A randomised trial of a program to reduce adverse drug effects , 2009, The journal of nutrition, health & aging.

[2]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[3]  D. Pollock,et al.  National surveillance of emergency department visits for outpatient adverse drug events. , 2006, JAMA.

[4]  D. Platt,et al.  The aging liver: structural and functional changes and their consequences for drug treatment in old age. , 2002, Gerontology.

[5]  M. Cesari,et al.  Adverse drug reactions and cognitive function among hospitalized older adults , 2002, European Journal of Clinical Pharmacology.

[6]  D. Classen,et al.  Methodology and rationale for the measurement of harm with trigger tools , 2003, Quality & safety in health care.

[7]  Viv Bewick,et al.  Statistics review 13: Receiver operating characteristic curves , 2004, Critical care.

[8]  Joshua Borus,et al.  Adverse drug events in ambulatory care. , 2003, The New England journal of medicine.

[9]  D. Greenblatt,et al.  A method for estimating the probability of adverse drug reactions , 1981, Clinical pharmacology and therapeutics.

[10]  L C Mion,et al.  Adverse drug reactions in an elderly outpatient population. , 1992, American journal of hospital pharmacy.

[11]  David W. Hosmer,et al.  Applied Logistic Regression , 1991 .

[12]  Katherine E Henson,et al.  Risk of Suicide After Cancer Diagnosis in England , 2018, JAMA psychiatry.

[13]  G. Onder,et al.  Heart Failure and Adverse Drug Reactions Among Hospitalized Older Adults , 2009, Clinical pharmacology and therapeutics.

[14]  P. Gallagher,et al.  Adverse drug reactions in older patients during hospitalisation: are they predictable? , 2012, Age and ageing.

[15]  C. Holman,et al.  Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study , 2009, BMJ : British Medical Journal.

[16]  I. Edwards,et al.  Adverse drug reactions: definitions, diagnosis, and management , 2000, The Lancet.

[17]  R S Evans,et al.  Computerized surveillance of adverse drug events in hospital patients* , 2005, Quality and Safety in Health Care.

[18]  B. Tangiisuran,et al.  Adverse drug reactions in a population of hospitalized very elderly patients. , 2012, Drugs & aging.

[19]  R. Resar,et al.  Adverse drug event trigger tool: a practical methodology for measuring medication related harm , 2003, Quality & safety in health care.

[20]  Subashan Perera,et al.  Consensus List of Signals to Detect Potential Adverse Drug Reactions in Nursing Homes , 2008, Journal of the American Geriatrics Society.

[21]  J. Hanlon,et al.  Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[22]  F. Follath,et al.  Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. , 2000, British journal of clinical pharmacology.

[23]  D. Pollock,et al.  National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. , 2008, The Journal of pediatrics.

[24]  T. V. D. van der Cammen,et al.  Adverse drug reactions in elderly patients as contributing factor for hospital admission: cross sectional study , 1997, BMJ.

[25]  Graziano Onder,et al.  Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. , 2010, Archives of internal medicine.

[26]  C. Pedone,et al.  Concealed renal failure and adverse drug reactions in older patients with type 2 diabetes mellitus. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[27]  J. Hallas,et al.  Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention , 1990, Journal of internal medicine.

[28]  J. McElnay,et al.  Development of a Risk Model for Adverse Drug Events in the Elderly , 1997 .

[29]  M. Pirmohamed,et al.  Which drugs cause preventable admissions to hospital? A systematic review. , 2007, British journal of clinical pharmacology.

[30]  R. D'Agostino,et al.  Sudden death risk in overt coronary heart disease: the Framingham Study. , 1987, American heart journal.

[31]  D. Platt,et al.  The Aging Liver , 2002, Gerontology.